Passage of Federal regulations in the manufacturers' and pharmacies' LABELING of products containing steroid ingredients to specify "STEROID."Promotion of physician and public AWARENESS through physician education concerning the adverse affects of steroids; and emphasis on and adherence to manufacturers' recommendations for PRECAUTIONS and TESTING with regard to individual products.
Food and Drug Administration (FDA) approval of Pivalate and Budesonide Screening patches that can identify more than 80% of cases of steroid hypersensitivity.
Physicians need to keep an accurate and current prescription record, including all physician-approved refills
The percentage of each steroid contained in products needs to be listed on the manufacturers' labeling.
